Cite
HARVARD Citation
Yi, L. et al. (2020). IKBKE, a prognostic factor preferentially expressed in mesenchymal glioblastoma, modulates tumoral immunosuppression through the STAT3/PD‐L1 pathway. Clinical and translational medicine. 10 (3), p. n/a. [Online].